Gauging The Role And Impact Of Drug Interactions And Repurposing in Neurodegenerative Disorders Part 3

4.1.1. Genes associated with lipid metabolism

ABCA7 (ATP binding cassette transporter A7) gene located on chromosome 19p13.3 is highly expressed in hippocampus CA1 neuron and microglial cells and encodes for ABCA7 for lipoprotein transport in the cell. 

Microglia are important nerve cells responsible for maintaining normal functions of the nervous system and affecting human cognition and memory. A growing body of research shows that microglia function has a positive impact on human health and well-being.

First, microglia can enhance memory. Memory is divided into short-term memory and long-term memory, and microglia are mainly involved in the cognitive process of long-term memory. When humans perform long-term memory, microglia release neurotransmitters to neurons to promote the interconnection between neurons, thus accelerating the memory process. Therefore, for those who want to enhance their memory, it is very important to maintain the health of microglia in the brain.

In addition, microglia can slow down aging-related cognitive damage. As we age, human cognitive abilities also gradually decline, which is often related to the death, atrophy, and inactivation of brain cells. However, research shows that microglia can promote the regeneration and protection of neurons and reduce the occurrence of cognitive impairment. This also illustrates the importance of maintaining the normal function of microglia in preventing diseases such as Alzheimer's disease.

In general, microglia are closely related to human cognition and memory. Their health status not only has a positive impact on people's quality of life, career development, and other aspects but can also reduce aging-related cognitive damage and improve the health of the elderly. quality of life. Therefore, we should pay more attention to the health of microglia and adopt appropriate lifestyle, dietary habits, and exercise methods to promote their normal function. It can be seen that we need to improve memory, and Cistanche deserticola can significantly improve memory, because Cistanche deserticola can also regulate the balance of neurotransmitters, such as increasing the levels of acetylcholine and growth factors. These substances are very important for memory and learning. In addition, Cistanche deserticola can also improve blood flow and promote oxygen delivery, which can ensure that the brain receives sufficient nutrients and energy, thereby improving brain vitality and endurance.

Click know supplements to improve memory

In GWAS the G allele rs3764650 SNP was found to be the risk factor for AD as it is associated with hippocampal and cortical atrophy and cognitive deficits in patients (Almeida et al., 2018).

4.1.2. Gene associated with immune response and inflammation

Neuroinflammation is one of the essential hallmarks of AD which is the response of the immune system.CR1 is located on chromosome 1q32 which is expressed widely in blood cells. CR1 codes for complementary regulatory proteins. 

A study found rs6656401, an SNP variant that is strongly associated with LOAD (Lambert et al., 2009). EPHA1 is located on chromosome 7q34 and is a member of the tyrosine kinase family. This gene is implicated in immune function, chronic inflammation, synaptic plasticity, and cellular membrane processes. The SNP, rs11767557 was associated with a decreased risk of LOAD (Hollingworth et al., 2011). 

TREM2 (Triggering receptor expressed on myeloid cell 2) gene is located on chromosome 6q21.1, highly expressed on the cell surface of microglia and throughout the central nervous system, and encodes for single-pass type 1 membrane (Giri et al., 2016). 

Replogle et al. reported variant G rs6910730 to be associated with cognitive decline. A rare TREM2 missense variant T rs75932628 was strongly associated with AD pathology (Replogle et al., 2015).

4.1.3. Genes associated with endocytosis and synaptic function

CD2AP is located on chromosome 6p12, expressed in the brain and AD patients, and encodes for CD2-associated protein which is a scaffolding molecule and regulates the actin cytoskeleton. It is functionally involved in receptor-mediated endocytosis, apoptosis, cell adhesion, and intracellular trafficking. SNP rs9296559 and rs9349407 in CD2AP are suspected to be at risk of LOAD. 

SNP rs9349407 is associated with neuritic plaque (Shulman et al., 2013). The CD2AP gene is strongly associated with LOAD risk and plays an important role in receptor-mediated endocytosis, which is believed to be disrupted during the early stages of AD (Dunstan et al., 2016). PICLAM (Phosphatidylinositol binding Clathrin assembly protein) is located on chromosome 11q14, expressed in all tissues and prominently in neurons. 

PICLAM is involved in clathrin-mediated endocytosis and also appears to be involved in the trafficking of VAMP (Harold et al., 2009). SNP rs3851179 is associated with the thickening of the entorhinal cortex and hippocampal degeneration and rs3851179 & APOE ε4 are strongly associated with brain atrophy and cognitive decline (Biffi et al., 2010).

4.2. Parkinson's disease

PD is the second most prevalent irreversible, progressive, complex ND after Alzheimer's, which affects almost 2–3% of the total population above the age of 65 years. The neuropathological hallmark includes dopaminergic neuronal loss in the substantia nigra and aggregates of α-synuclein (Poewe et al., 2017). From 1990 to 2016 the cases of Parkinson's have almost increased by 2.4 times (Collaborators and G.B.D.P.s.D, 2018). 

PD was first considered to be a non-genetic disorder and only of 'sporadic' origin, but in the last few decades, it was found to be strongly associated with genetic background. Along with the environmental factors, hereditary factors are equally responsible for the risk of PD. The multiple genetic loci and genes that are associated with PD are as follows: PARK1 & PARK4 locus both are mapped on chromosome 4q21 and and associated with SNCA, a gene that encodes for α-synuclein. 

Three rare missense mutations: A53T, A30P, and E46K occur in SNCA, from which A53T was found most frequently. Duplication and triplication of PARK4 are considered to be toxic. Duplication of genes resembles idiopathic PD while triplicate is responsible for early onset and rapid disease advancement (Lesage and Brice, 2009). 

Mutations (duplication/- triplication) are pathologically responsible for cognitive decline, autonomic dysfunction, and neuronal loss in the nigral and hippocampal regions (Farrer, 2006). PARK2 loci are plotted on chromosome 6q25.2 and are associated with the parkin gene, mutations may lead to an autosomal recessive form of PD. Parkin is a ubiquitin e3 ligase that works along with PINK1 in regulating mitophagy. 

A study reported that compound heterozygotic mutations in PARK2 with single point mutation of G403C and deletion mutation of exon 6 might contribute to the development of EOPD (Fang et al., 2019). The loci are associated with Lewy body and tau pathology and also with neuronal loss in the nigral region. 

PARK5: The UCHL1 (Ubiquitin carboxyl-terminal esterase L1) gene on loci PARK5 is located on chromosome 4p14, and encodes for ubiquitin thiolesterase. The UCHL1 protein is amply present in neurons throughout the brain. This protein is associated with the ubiquitin-proteasome system, which helps in removing abnormal and misfolded proteins. 

A Missense mutation in this gene occurs by replacing amino acid leucine with methionine at 93 position (I93M), which results in a disruption in the normal functioning of the ubiquitin-proteasome system. This mutation is associated with autosomal dominant PD (Selvaraj and Piramanayagam,2019). PARK6: PARK6 locus is located on chromosome 1p 36 associated with the PINK1 (PTEN-induced kinase 1) gene, a mitochondrial serine/ threonine protein kinase, and is associated with autosomal recessive early onset of PD. 

PINK1's function is to identify the damaged mitochondria to prevent their accumulation inside the cell. PINK1 p.I3689 mutation is found to be involved in PD which affects kinase activity and PARKIN activation (Ando et al., 2017). PARK7: PARK7 loci associated with DJ-1gene located on chromosome 1p36.23, is also responsible for autosomal recessive PD. 

It is known to be involved in the protection of the brain from oxidative stress. Takahashi-niki K et al. found 4 mutants associated with DJ-1 out of which two were homozygous mutations (L166P, M26I0) and two heterozygous mutations (R98Q, D1498) (Takahashi-Niki et al., 2004). After the mutation, the normal functionality like its antioxidant and neuroprotective effects of the protein is lost. 

PARK8: PARK8 locus is identified on chromosome 12q12, associated with LRRK2 (leucine-rich repeat kinase 2). It helps in vesicular transport, protein-protein interaction, and also in autophagy (Selvaraj and Piramanayagam, 2019). Several mutations are involved in LRRK2 which can be held responsible for phosphorylation of α-synuclein and tau, a key factor associated with aggregation and accumulation of unfolded protein in many ND (Zimprich et al., 2004). PARK9: Located on chromosome 1p36 and is associated with ATP13A2 (ATPase 13A2) gene. 

Several missense mutations have been known to cause PD pathogenicity but the exact mechanism is still unknown (Klein and Westenberger, 2012). Mutation in ATP13A2 is not only associated with PD but also in other NDs like Kufor-Rabef syndrome and neuronal ceroid lipofuscinoses. Similarly, PARK10 identified on chromosome 1p32 remains to be associated with a gene. In addition to all these causative PD genes, several PARK loci are identified by GWAS for causing pathogenicity in PD patients. 

In a recent meta-analysis, more than 800 GWAS have found multiple loci associated with PD like CCD62/H1P1R, ACMSD/THEMI63, DGKQ/GAK, HLA, MCCC1/LAMP3, ITGA8, STK39, and SYT11/RAB25 (Zhang et al., 2018a). Other ND which involves multiple gene mutations in their pathology are:

4.3. Multiple sclerosis

MS is a chronic, inflammatory, autoimmune disorder affecting the CNS. Th1 and Th17 are the major pathogenetic factor as they produce pro-inflammatory cytokines and chemokines like IL-6, IL-9, IL-12, IL-17, IL-21, IL-22, IL-23, IL-26, TNF-α, TNF-β, and INF-γ (Jadidi-Niaragh and Mirshafiey, 2011). 

The IL-6 functional gene is located on chromosome 7p21; it is responsible for the activation of microglia and astrocytes, induction of cerebrovascular adhesion molecules, and transportation of B & T lymphocytes across BBB into the CNS. An SNP in rs1800975 has been found as a risk factor for MS. Another important proinflammatory factor IL-7gene is found to be located on chromosome 5p13.2, which encodes for CD127 protein. 

It plays a crucial role in the modulation of T lymphocytes. A causal variation in gene SNP rs6897932 in exon6 was also observed to be impacting MS. Similarly, IL7RA rs3194051, rs6897932, rs987107, and rs11567686 variants may be involved in contributing genetic susceptibility to MS (Benesova et al., 2018). Also, HLA (Human leukocyte antigen) DRB1*1501 is one of the major genes thought to be involved in MS (Alcina et al., 2012).

4.4. Amyotrophic lateral sclerosis

ALS is a fatal, progressive ND. There are a plethora of genes that are associated with ALS: SOD1gene is located on chromosome 21q22.1, and it is documented to have more than 150 mutations which are seen to be spread all over the translated protein. 

Such aberrant protein aggregates when accumulated, may result in the death of motor neurons leading to the development of ALS phenotype. Out of all the genes, a genetic mutation in SOD1 alone accounts for up to 20% of familial type ALS. 

The second important gene associated with ALS is TARDBP located on chromosome 1 and codes for TDP-43 protein which plays an important role in regulating RNA splicing and transport. In dysregulated/pathological neurons, TDP-43 is found to be ubiquitinated in cytoplasm-forming aggregates (Jeon et al., 2019). 

In a study, a single base pair change at position 1028 (A1028G) in TDP-43 was found to be affected in familial ALS (Yokoseki et al., 2008). Other mutated genes involved in the progression of ALS are ANG, FUS, VCP, OPTN, C9Oorf72, UBQLN2, SQSTM1, MATR3, and TBK1 (Taylor et al., 2016).

4.5. Huntington's disease

HD is a fatal, single-gene disorder that involves a mutation in CAG triplicate repeat at the start point of the exon in the HTT gene on chromosome 6. Almost 10–35 abnormal repeats have been linked to HD (Ghosh and Tabrizi, 2018). 

Such a gene when translated forms a cytotoxic protein (in this case Huntingtin) with long polyglutamine tracts. In short, it can be concluded that all neurogenerative diseases, in one or the other way, are associated with multiple genes and are of multifactorial origin. The gene mutation in one disease may be the risk factor for the other disease. 

As a result, still more research is needed to be done in the field of genetics to understand the pathological role of genes related to ND in a better way. Genes mentioned above are briefly summarized in Table 1.

5. Polypharmacology

Every drug molecule available in the pharmaceutical market is a chemical compound made up of numerous heterocyclic scaffolds substituted with different functional groups. 

The functional groups along with the stereochemistry determine the target affinity of the drug molecule. Specific drug-target interaction produces a therapeutic effect while at the same time, unintended drug-target interaction may lead to some serious side effects. 

Polypharmacology is a broad term that refers to either a single drug acting on multiple targets or a combination of drugs that can modulate multiple targets simultaneously to resolve the pathogenic symptoms of a particular disease (Reddy and Zhang, 2013; Jalencas and Mestres, 2013; Albertini et al., 2020). The drug discovery program in previous years had a major focus on "one drug-one target strategy". 

However, the failure of any single monofunctional targeted drug to show considerable therapeutic benefits in complex neurodegenerative conditions like Alzheimer's and Parkinson's is leading to a gradual shift towards polypharmacological drug discovery. 

Also, the multifactorial nature of ND and the curiosity to discover possible off-targets for current therapeutic drugs (drug repurposing) serves as an additional motivating factor to move towards a polypharmacological approach for the treatment of ND.

5.1. One drug-multiple target polypharmacological approach

Drugs classified under this group are also called multi-target directed ligands (MTDL) or simply multi-target ligands/drugs (Albertini et al., 2020). MTDLs when compared to the already existing single monofunctional targeted drugs can target multiple signaling pathways at the same time and as a result, MTDLs show greater therapeutic efficacy credited because of their synergistic or additive mechanisms. 

Also, the chances of drug resistance by other biological compensating mechanisms and by gene mutations are reduced (Van der Schyf, 2011). MTDLs is a broad term and can be further classified into 1) Co-ligands and 2) Hybrid ligands. 

A technical comparison between both classes of ligands is shown in Fig. 3. A few MTDLs that are not yet approved but might show therapeutic benefit in various ND conditions are discussed in the following section.

For more information:1950477648nn@gmail.com